Work

Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy

Year: 2019

Type: article

Source: Nature Nanotechnology

DOI: 10.1038/s41565-018-0342-5

Authors: Daniel Shae, Kyle W. Becker, Plamen Christov, Dong Soo Yun, Abigail K. R. Lytton-Jean, Sema Sevimli, Manuel Ascano, Mark Kelley, Douglas B. Johnson, Justin M. Balko, John T. Wilson

Institutions: Vanderbilt University, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Vanderbilt University Medical Center, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Predicting and profiling long-term survival after immune checkpoint inhibition, Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension, Dusp4 in breast cancer: tumor suppressor biology and therapeutic strategies, Vanderbilt Clinical Oncology Research Career Development Award, Molecular and Cellular Basis for Digestive Diseases, Cancer Center Support Grant, Deciphering Post-transcriptional Gene Regulatory Networks During Periods of Host-Pathogen Interaction and Innate Immune Activation, Long-Term Cardiovascular Sequelae of Cancer Immunotherapies

OpenAlex ID: W2909554490

FWCI: 27.82

Cites: 57

Cited by: 678

Related to: 10